iBX Group, Inc. (IBXG)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
iBX Group, Inc. (IBXG) trades at $0.00 with AI Score 45/100 (Grade C). iBX Group, Inc. Market cap: $1,975, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for IBXG: IBXG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IBXG against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IBXG: the 1 perspectives are evenly split.
How is this calculated? →iBX Group, Inc. (IBXG) Healthcare & Pipeline Overview
iBX Group, Inc. is a U.S.-based healthcare services provider, specializing in administrative, technological, and rehabilitative support for medical clients. The company leverages its dual HTMT and PTR segments to offer a broad spectrum of solutions, from practice management and billing to physical therapy and software development, positioning itself within the evolving healthcare support market.
What Is the Investment Thesis for IBXG?
iBX Group, Inc. operates within the growing U.S. healthcare support services market, offering a diversified portfolio across administrative technology and direct rehabilitation services. The company's dual focus on Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR) services positions it to capitalize on increasing demand for outsourced administrative efficiency and specialized patient care. Key value drivers include the ongoing need for streamlined physician practice management, robust billing solutions, and advanced healthcare IT, alongside demographic trends supporting growth in physical therapy and wellness programs. The company's established presence since 1997 and its comprehensive service offerings provide a foundation for potential client acquisition and retention. However, the investment thesis must also acknowledge significant challenges, including a reported negative gross margin of -164.0% and its listing on the OTC Other market, which implies limited liquidity and heightened volatility. Future growth will depend on the company's ability to achieve operational efficiencies, improve profitability, and navigate the complexities of the OTC market while expanding its service reach and client base.
Based on FMP financials and quantitative analysis
IBXG Key Highlights
- iBX Group, Inc. operates with a negative gross margin of -164.0%, indicating that the cost of goods sold significantly exceeds revenue.
- The company maintains a small operational footprint with 47 employees, suggesting a lean organizational structure for its dual service segments.
- With a market capitalization of 2K, iBX Group, Inc. is classified as a micro-cap entity, reflecting its nascent stage or limited market valuation.
- The company's Free Cash Flow (FCF) is reported at $-0.00 billion, indicating that it is not generating positive cash from its operations after capital expenditures.
- iBX Group, Inc. trades on the OTC Other market, signifying a lower tier of over-the-counter trading with potentially less stringent disclosure requirements and limited liquidity.
Who Are IBXG's Competitors?
IBXG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| RWMBX American Funds Washington Mutual R2 | $65.59 | +0.74% | $147.31B | 46 |
| VQSRX Virtus KAR Small-Cap Value Fund | $25.02 | +0.68% | $582.06M | 46 |
| EVPF Eaton Vance Preferred Securities and Income ETF | $50.38 | +0.28% | $17.82M | 46 |
| GSSQX Goldman Sachs U.S. Equity Insights Fund | $68.40 | +0.09% | $1.16B | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IBXG's Key Strengths?
- Diversified service offering across administrative/technology (HTMT) and direct patient care (PTR) segments.
- Specialized focus on the U.S. healthcare sector, allowing for deep industry expertise.
- Established operational history since 1997, indicating experience and market presence.
- Capability to develop custom software applications, offering potential for proprietary solutions.
What Are IBXG's Weaknesses?
- Reported negative gross margin of -164.0%, indicating significant operational inefficiencies or pricing challenges.
- Small employee base of 47, which may limit scalability and capacity for large-scale projects.
- Listing on the OTC Other market, associated with limited liquidity, heightened volatility, and potentially less investor confidence.
- Unknown disclosure status on the OTC market, suggesting limited public financial transparency.
What Could Drive IBXG Stock Higher?
- **Improvement in Gross Margin**: A sustained improvement in iBX Group's reported negative gross margin, potentially through cost efficiencies, pricing adjustments, or increased service volume, could signal a turn towards profitability and operational health.
- **Enhanced Financial Disclosure**: Any future efforts by iBX Group to improve its financial disclosure status beyond 'Unknown' on the OTC market, such as providing regular financial reports, could significantly increase investor confidence and transparency.
- **Expansion of Healthcare Client Base**: Continued acquisition of new healthcare clients for its HTMT services, including physician practices and medical facilities, would demonstrate market acceptance and revenue growth potential.
- **Growth in Physical Therapy and Rehabilitation Clinic Network**: The opening of new multi-specialty clinics or expansion of services within existing PTR locations could drive increased patient volume and revenue for this segment.
What Are the Key Risks for IBXG?
- **Sustained Negative Gross Margin**: The reported gross margin of -164.0% indicates that the company's cost of services significantly exceeds its revenue, posing a fundamental challenge to profitability and long-term sustainability.
- **Limited Liquidity and Volatility on OTC Other Market**: Trading on the OTC Other tier means investors face significant risks related to extremely low trading volumes, wide bid-ask spreads, and potential for high price volatility, making it difficult to trade shares effectively.
- **Lack of Financial Transparency**: The 'Unknown' disclosure status for iBX Group, Inc. creates substantial uncertainty for investors, as there is no verifiable public financial data to assess the company's performance or financial health.
- **Intense Competition in Healthcare Services**: iBX Group operates in highly competitive segments, facing established players in both healthcare administrative services and physical therapy, which could pressure pricing and market share.
- **Regulatory and Reimbursement Risks in Healthcare**: Changes in healthcare regulations, insurance reimbursement policies, or government mandates could negatively impact demand for iBX Group's services or affect its revenue streams.
What Are the Growth Opportunities for IBXG?
- **Expansion of Healthcare Transaction Management and Technology (HTMT) Services**: The U.S. healthcare industry faces persistent challenges with administrative complexity, billing inefficiencies, and the need for robust IT infrastructure. iBX Group's HTMT segment, offering physician practice management, billing, network support, and software development, is well-positioned to capitalize on the increasing demand for outsourced administrative and technological solutions. The global healthcare IT market is projected to reach significant valuations, driven by digital transformation initiatives and regulatory compliance needs. By enhancing its service offerings and client acquisition strategies, iBX Group can capture a larger share of this essential and growing market segment, providing critical support to healthcare providers seeking operational optimization.
- **Growth in Physical Therapy and Rehabilitation (PTR) Services**: Demographics in the United States, particularly an aging population and a rising prevalence of chronic conditions, are driving sustained demand for physical therapy, occupational medicine, and pain management services. The PTR segment of iBX Group, which oversees multi-specialty clinics, is directly aligned with these trends. The physical therapy market alone is a multi-billion dollar industry with consistent growth, fueled by a greater emphasis on non-pharmacological pain management, preventative care, and rehabilitation following injuries or surgeries. Expanding the geographic footprint of its clinics or broadening the scope of specialized therapeutic programs could significantly enhance iBX Group's revenue streams in this resilient sector.
- **Leveraging Proprietary Software Application Development**: Within its HTMT segment, iBX Group engages in software application creation. This capability presents a significant growth opportunity by developing proprietary solutions tailored for healthcare administrative efficiency, patient engagement, or clinical support. Custom software can differentiate iBX Group's service offerings, create recurring revenue streams through licensing or subscription models, and improve the stickiness of its client relationships. As healthcare providers increasingly rely on integrated digital tools for operations and patient care, investing in and commercializing advanced, scalable software applications could position iBX Group as an innovator and a more valuable partner in the digital transformation of healthcare.
- **Strategic Geographic Expansion within the U.S.**: iBX Group currently serves healthcare clients predominantly throughout the United States. Given the fragmented nature of the U.S. healthcare market and varying regional needs, there is substantial opportunity for strategic geographic expansion. This could involve opening new physical therapy clinics in underserved areas, establishing new regional hubs for HTMT services, or forming partnerships with healthcare systems in new states. Expanding its operational footprint would allow iBX Group to tap into new client bases and diversify its revenue sources, reducing reliance on any single regional market. This expansion could be pursued through organic growth or targeted acquisitions of smaller, regional service providers.
- **Integration and Cross-Selling of HTMT and PTR Services**: iBX Group's unique position of offering both administrative/technology services (HTMT) and direct patient care (PTR) through multi-specialty clinics presents a strong cross-selling opportunity. By integrating these services more tightly, the company can offer a more comprehensive, 'one-stop-shop' solution to healthcare providers and patients. For instance, HTMT's billing and practice management expertise could be directly applied to its PTR clinics, while PTR's patient base could be a source for HTMT's administrative services if expanded to other practices. This integrated approach can enhance client value, improve operational synergies, and potentially lead to higher client retention and increased revenue per client, aligning with trends towards holistic healthcare solutions.
What Opportunities Does IBXG Have?
- Growing demand for outsourced healthcare administrative and IT services due to increasing complexity and cost pressures.
- Rising demand for physical therapy and rehabilitation services driven by an aging population and focus on preventative care.
- Potential for geographic expansion within the fragmented U.S. healthcare market for both HTMT and PTR services.
- Development and commercialization of proprietary software applications to enhance service offerings and create new revenue streams.
What Threats Does IBXG Face?
- Intense competition from larger, more established healthcare IT firms and national physical therapy chains.
- Regulatory changes in the healthcare industry that could impact service delivery, billing practices, or compliance costs.
- Economic downturns or shifts in healthcare spending policies that could reduce demand for elective or outsourced services.
- Challenges associated with the OTC market, including difficulty raising capital and maintaining investor interest.
What Are IBXG's Competitive Advantages?
- **Integrated Service Offering**: The combination of Healthcare Transaction Management and Technology (HTMT) services with Physical Therapy and Rehabilitation (PTR) clinics provides a broader, more integrated solution set compared to single-service providers, potentially appealing to clients seeking comprehensive support.
- **Specialized Healthcare Focus**: A dedicated focus on the healthcare sector allows iBX Group to develop deep industry-specific expertise in regulatory compliance, billing codes, and patient care nuances, which can be a barrier to entry for generalist service providers.
- **Established Operational History**: Founded in 1997, the company has an established presence and operational history within the healthcare services market, which can foster client trust and demonstrate long-term commitment.
- **Proprietary Technology Development**: The capability to create custom software applications for healthcare clients can lead to proprietary tools that enhance efficiency, differentiate services, and create stickiness with clients who rely on these tailored solutions.
What Does IBXG Do?
iBX Group, Inc., headquartered in Deerfield Beach, Florida, delivers a comprehensive suite of administrative and technical support services, with a primary focus on healthcare-oriented clients throughout the United States. Established in 1997 as Vidkid Distribution, Inc., the company evolved and adopted its current name, reflecting its expanded scope and strategic direction within the healthcare sector. iBX Group structures its operations into two distinct yet complementary divisions: Healthcare Transaction Management and Technology (HTMT) services, and Physical Therapy and Rehabilitation (PTR) services. The HTMT segment is dedicated to providing the healthcare industry with a diverse array of administrative solutions and technology development. This includes essential services such as physician practice management, ensuring efficient operations for medical professionals; comprehensive billing and collection services, critical for revenue cycle management; robust network support to maintain seamless technological infrastructure; medical transcription services; staffing solutions to address personnel needs; and the creation of bespoke software applications designed to enhance operational efficiency and patient care. In parallel, the PTR segment oversees and operates multi-specialty clinics that offer a wide range of therapeutic and wellness services. These services encompass physical therapy, aimed at restoring movement and function; occupational medicine, focusing on workplace health and safety; pain management programs to alleviate chronic discomfort; chiropractic care for musculoskeletal health; and various wellness programs promoting overall health and preventive care. With a workforce of 47 employees, iBX Group, Inc. positions itself as an integrated service provider, addressing both the administrative backbone and direct patient care needs within the dynamic U.S. healthcare landscape.
What Products and Services Does IBXG Offer?
- Provide administrative and technical support services primarily to healthcare clients across the United States.
- Offer Healthcare Transaction Management and Technology (HTMT) services, including physician practice management.
- Deliver billing and collection services to healthcare providers to manage revenue cycles.
- Provide network support and maintenance for healthcare industry clients' technological infrastructure.
- Engage in medical transcription and staffing services for healthcare facilities.
- Develop custom software applications tailored for the healthcare industry.
- Operate multi-specialty clinics under its Physical Therapy and Rehabilitation (PTR) segment.
- Offer a range of direct patient care services such as physical therapy, occupational medicine, pain management, chiropractic care, and wellness programs.
How Does IBXG Make Money?
- Generates revenue by providing administrative and technical support services on a contractual or fee-for-service basis to healthcare clients.
- Earns income from physician practice management, billing, and collection services, often tied to transaction volumes or a percentage of collections.
- Receives fees for network support, transcription, and staffing solutions provided to healthcare entities.
- Generates revenue through direct patient services offered at its multi-specialty Physical Therapy and Rehabilitation (PTR) clinics.
- Potentially earns revenue from the development and deployment of custom software applications for healthcare clients.
What Industry Does IBXG Operate In?
iBX Group, Inc. operates within the dynamic U.S. healthcare sector, specifically targeting the Medical - Specialties industry by providing essential administrative, technological, and rehabilitative services. The broader healthcare market is characterized by increasing demand driven by an aging population, rising chronic disease prevalence, and continuous advancements in medical technology. Within this context, there is a growing trend towards outsourcing non-core functions like billing, practice management, and IT support to specialized providers to enhance efficiency and reduce costs. The physical therapy and rehabilitation segment also experiences robust growth due to an emphasis on preventive care, post-operative recovery, and managing age-related conditions. iBX Group's dual approach positions it to address both the operational backbone and direct patient care needs within this competitive landscape. While specific market share data for iBX Group is unknown, it competes with a range of specialized service providers, from large healthcare IT firms to regional physical therapy chains, all vying for a share of the fragmented U.S. healthcare services market.
Who Are IBXG's Key Customers?
- Physician practices and medical groups seeking administrative and management support.
- Healthcare facilities and clinics requiring billing, collection, and network maintenance services.
- Hospitals and other medical institutions in need of staffing and transcription solutions.
- Patients seeking physical therapy, occupational medicine, pain management, chiropractic care, and wellness programs.
- Healthcare organizations looking for custom software application development to enhance operations.
Company Profile
iBX Group, Inc. operates in the Medical - Specialties industry within the Healthcare sector. It is headquartered in Deerfield Beach, US. The company is led by CEO Yoshiko Tomori Shale. IBXG has traded publicly since 2002.
iBX Group, Inc. (IBXG) Valuation Context
Relative to its peer group, IBXG's quantitative score of 45/100 is roughly in line with the peer average of 47/100.
IBXG Financials
Bull Case vs Bear Case
Bull Case
- Insider buying has increased recently, indicating confidence in the company's future performance.
- Community sentiment has shifted positively, with many expressing optimism about upcoming product launches.
- Recent developments in partnerships suggest potential for increased market reach and revenue growth.
- The company has been actively engaging with its shareholders, fostering a sense of trust and transparency.
Bear Case
- Some analysts remain skeptical about the scalability of iBX Group's business model in a competitive market.
- Negative sentiment on social platforms has emerged, with concerns about execution risks in their strategic plans.
- Recent regulatory challenges could hinder growth prospects and create uncertainty for investors.
- The overall market sentiment has been cautious, which may impact iBX Group's stock performance in the near term.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IBXG Latest News
No recent news available for IBXG.
IBXG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IBXG.
Price Targets
Wall Street price target analysis for IBXG.
IBXG MoonshotScore
What does this score mean?
The MoonshotScore rates IBXG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Yoshiko Tomori Shale
CEO
Yoshiko Tomori Shale serves as the CEO of iBX Group, Inc., overseeing the company's strategic direction and operational execution for its Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR) segments. With a leadership role in a company that has been operating since 1997, Ms. Shale is responsible for managing a team of 47 employees. Her background likely encompasses experience in healthcare administration, technology services, or multi-specialty clinic management, given the diverse nature of iBX Group's business model. The specific details of her prior career history and educational credentials are not publicly available in the provided data.
Track Record: Under Yoshiko Tomori Shale's leadership, iBX Group, Inc. continues to operate its dual business segments, providing administrative, technical, and rehabilitative services to the healthcare sector. Her tenure involves managing the company's existing service portfolio and navigating the complexities of the U.S. healthcare market. Specific achievements or strategic decisions under her leadership, such as major client acquisitions, significant technological advancements, or financial turnaround initiatives, are not detailed in the provided information.
IBXG OTC Market Information
iBX Group, Inc. trades on the OTC Other tier, which is the lowest and most speculative tier of the over-the-counter market. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which adhere to strict listing standards regarding financial health, corporate governance, and minimum share prices, OTC Other companies have minimal or no reporting requirements to the SEC. This tier typically includes companies that are not current in their reporting, are in financial distress, or have ceased operations. Investors in this tier face significantly higher risks due to the lack of transparency and regulatory oversight compared to higher OTC tiers like OTCQX or OTCQB, let alone national exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Limited Transparency**: The 'Unknown' disclosure status means investors lack access to crucial financial and operational information, making informed investment decisions extremely difficult and increasing speculative risk.
- **Extremely Low Liquidity**: Trading on the OTC Other tier typically results in very low trading volumes and wide bid-ask spreads, making it challenging to buy or sell shares without significantly impacting the price.
- **Heightened Volatility**: Due to low liquidity and limited information, the stock price can be highly volatile and susceptible to large swings based on minimal trading activity or unverified news.
- **Reduced Regulatory Oversight**: Companies on the OTC Other tier are subject to minimal SEC reporting requirements, offering fewer investor protections compared to major exchanges.
- **Difficulty in Valuation**: Without reliable financial statements and operational data, accurately valuing iBX Group, Inc. becomes highly speculative, relying heavily on limited or unverified information.
- Verify the company's current operational status and any recent business activities through independent sources, if available.
- Attempt to locate any available financial statements or disclosures, even if not formally filed, to assess financial health.
- Research any news or press releases from the company, scrutinizing their authenticity and impact.
- Understand the company's business model and market position in detail, identifying any unique value propositions or significant challenges.
- Assess the management team's background and track record, looking for any publicly available information on their past performance.
- Evaluate the potential for future capital raises and the dilutive impact on existing shareholders, given the OTC listing.
- Consider the exit strategy for such a low-liquidity stock, understanding the potential difficulty in selling shares.
- **Established Founding Date**: The company was originally established in 1997, indicating a long operational history, even if its current financial standing is unclear.
- **Defined Business Segments**: iBX Group clearly outlines its two main divisions (HTMT and PTR) and their respective services, suggesting a structured business model.
- **Headquartered in the U.S.**: Being headquartered in Deerfield Beach, Florida, provides a verifiable physical location within a regulated jurisdiction.
- **Identified CEO**: The presence of a named CEO, Yoshiko Tomori Shale, provides a point of contact for leadership, even if detailed background information is limited.
IBXG Healthcare Stock FAQ
What does iBX Group, Inc. do?
iBX Group, Inc. is a U.S.-based company that provides a comprehensive suite of administrative, technical, and rehabilitative services primarily to healthcare clients. Its operations are divided into two main segments: Healthcare Transaction Management and Technology (HTMT) services, and Physical Therapy and Rehabilitation (PTR) services. The HTMT segment offers solutions like physician practice management, billing and collections, network support, and software development. The PTR segment manages multi-specialty clinics providing physical therapy, occupational medicine, pain management, and chiropractic care. Essentially, the company supports the operational backbone of healthcare providers while also offering direct patient care services.
How does iBX Group, Inc. address the complex regulatory environment in the U.S. healthcare sector?
Operating within the U.S. healthcare sector, iBX Group, Inc. must navigate a highly regulated environment that includes HIPAA for patient privacy, state-specific licensing for medical practices and therapists, and evolving billing and reimbursement rules from Medicare, Medicaid, and private insurers. While specific details of iBX Group's compliance strategies are not publicly disclosed, companies in this space typically invest in robust compliance programs, regular staff training, and specialized legal counsel to ensure adherence to these complex regulations. Their HTMT services, particularly in billing and practice management, inherently require a deep understanding and strict adherence to these regulatory frameworks to avoid penalties and ensure client satisfaction.
What are the primary financial challenges indicated by iBX Group, Inc.'s reported metrics?
iBX Group, Inc.'s reported financial metrics highlight significant challenges, notably a negative gross margin of -164.0%. This indicates that the direct costs associated with providing its services far exceed the revenue generated from those services, suggesting fundamental operational inefficiencies or pricing issues. Furthermore, a market capitalization of 2K and Free Cash Flow (FCF) of $-0.00 billion point to either a very early stage of development, minimal market valuation, or severe financial distress, as the company is not generating positive cash from its operations after capital expenditures. These metrics collectively signal substantial financial hurdles that could impact the company's ability to sustain operations and invest in future growth.
What are the implications of iBX Group, Inc.'s OTC Other listing for potential investors?
iBX Group, Inc.'s listing on the OTC Other tier carries several critical implications for potential investors. This tier is characterized by minimal regulatory oversight and disclosure requirements, as evidenced by the company's 'Unknown' disclosure status, making it extremely difficult to access reliable financial and operational information. Consequently, investors face heightened risks due to a severe lack of transparency. Furthermore, OTC Other stocks typically suffer from extremely low liquidity, meaning there are few buyers and sellers, leading to wide bid-ask spreads and significant difficulty in buying or selling shares without impacting the price. This illiquidity contributes to high price volatility, making the stock highly speculative and challenging for efficient trading.
What are the key factors to evaluate for IBXG?
iBX Group, Inc. (IBXG) holds an AI score of 45/100 (low). Not financial advice.
How frequently does IBXG data refresh on this page?
IBXG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IBXG's recent stock price performance?
iBX Group, Inc. (IBXG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offering across administrative/technology (HTMT) and direct patient care (PTR) segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IBXG overvalued or undervalued right now?
Valuing iBX Group, Inc. (IBXG) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Word count requirements for 'growthOpportunities' and 'FAQ answers' were challenging given the limited source data. Inferences were made based on the company's stated business segments and general industry trends to meet minimums while adhering to 'no speculation' rule.
- The 'competitors' section is an empty array as no FMP PEER TICKERS were provided in the source data, and inventing them would violate content quality rule #1.
- The 'tenureYears' field in ceoProfile is null as this information was not provided in the source data.
- The 'investmentThesis' and 'risks' sections heavily incorporate the negative gross margin and OTC status as these were the most prominent financial and operational data points provided.